Sign In
Buy NBSE
$0.378
+0 (+0%)
At Close: Aug 09, 2024
Wait For It: Tech Testimony, Fed Meeting Both On Tap, With Facebook to Follow
12:00am, Wednesday, 29'th Jul 2020
The Wednesday wait is on, with two key things in focus: The Fed meeting that wraps up after lunch and today’s congressional testimony from tech executives where they’...
MRNA Stock Jumps 9%, Moderna Gets $472M for Vaccine Research
10:37am, Tuesday, 28'th Jul 2020
Moderna has got nearly $1B in support from the U.S. government so far to support the development of the COVID-19 vaccine, MRNA is up.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 27)
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT)
Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO)...
Coronavirus update: U.S. counts more than 1,000 fatalities for a fourth straight day as virus spread accelerates in South and West
11:37pm, Saturday, 25'th Jul 2020
The coronavirus illness COVID-19 claimed another 1,100 lives in the U.S. in a single day to push the death toll above 145,000 on Saturday, marking a fourth...
Zacks: Brokerages Expect NeuBase Therapeutics (NASDAQ:NBSE) Will Post Earnings of -$0.24 Per Share
06:24am, Monday, 20'th Jul 2020
Analysts expect NeuBase Therapeutics (NASDAQ:NBSE) to post earnings per share (EPS) of ($0.24) for the current quarter, according to Zacks Investment Research. Zero analysts have provided estimates fo
Heritage Wealth Advisors Sells 12,048 Shares of NeuBase Therapeutics (NASDAQ:NBSE)
08:48am, Sunday, 19'th Jul 2020
Heritage Wealth Advisors reduced its stake in shares of NeuBase Therapeutics (NASDAQ:NBSE) by 99.6% in the 2nd quarter, Holdings Channel reports. The firm owned 52 shares of the company’s stock afte
Ocular Therapeutix Is A Good Value Based On Its Strong Technology Platform (NASDAQ:OCUL)
06:02am, Thursday, 09'th Jul 2020
Ocular Therapeutix already has one marketed product and several promising pipeline therapies using its novel implant technology for the treatment of eye diseases.
OHR Pharmaceutical (NASDAQ:OHRP) and Prestige Consumer Healthcare (NASDAQ:PBH) Critical Analysis
01:50am, Saturday, 04'th Jul 2020
Prestige Consumer Healthcare (NYSE:PBH) and OHR Pharmaceutical (NASDAQ:OHRP) are both small-cap consumer discretionary companies, but which is the superior business? We will compare the two companies
Squarepoint Ops LLC Invests $449,000 in NeuBase Therapeutics (NASDAQ:NBSE)
07:24am, Friday, 03'rd Jul 2020
Squarepoint Ops LLC acquired a new position in shares of NeuBase Therapeutics (NASDAQ:NBSE) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. T
The Daily Biotech Pulse: Tiziana Snags A Patent Win, Decision Day For Nabriva And Evoke, IPOs
12:00am, Friday, 19'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 18)
ADC Therapeutics SA (NYSE:...
